Cytokine profile of breast cell lines after different radiation doses

References

• Balkwill F, Mantovani A. 2001. Inflammation and cancer: back to Virchow? Lancet. 357:539–545.
   PubMed Web of Science ®Google Scholar
• Becker KG, Hosack DA, Dennis G Jr, Lempicki RA, Bright TJ, Cheadle C, Engel J. 2003. PubMatrix: a tool for multiplex literature mining. BMC Bioinform. 4:61.
   PubMed Web of Science ®Google Scholar
• Bernier J, Hall EJ, Giaccia A. 2004. Radiation oncology: a century of achievements. Nat Rev Cancer. 4:737–747.
   PubMed Web of Science ®Google Scholar
• Bernier J, Viale G, Orecchia R, Ballardini B, Richetti A, Bronz L, Franzetti-Pellanda A, Intra M, Veronesi U. 2006. Partial irradiation of the breast: old challenges, new solutions. Breast. 15:466–475.
   PubMed Web of Science ®Google Scholar
• Bravatà V, Cammarata FP, Forte G, Minafra L. 2013a. “Omics” of HER2-positive breast cancer. OMICS. 17:119–129.
   PubMed Web of Science ®Google Scholar
• Bravatà V. 2015. Controversial roles of methylenetetrahydrofolate reductase polymorphisms and folate in breast cancer disease. Int J Food Sci Nutr. 66:43–49.
   PubMed Web of Science ®Google Scholar
• Bravatà V, Minafra L, Russo G, Forte GI, Cammarata FP, Ripamonti M, Casarino C, Augello G, Costantini F, Barbieri G, Messa C, Gilardi MC. 2015. High dose ionizing radiation regulates gene expression changes in MCF7 breast cancer cell line. Anticancer Res. 35:5.
   Web of Science ®Google Scholar
• Bravatà V, Stefano A, Cammarata FP, Minafra L, Russo G, Nicolosi S, Pulizzi S, Gelfi C, Gilardi MC, Messa C. 2013b. Genotyping analysis and 18FDG uptake in breast cancer patients: a preliminary research. J Exp Clin Cancer Res. 32:23.
   PubMed Web of Science ®Google Scholar
• Campa A, Balduzzi M, Dini V, Esposito G, Tabocchini MA. 2013. The complex interactions between radiation induced non-targeted effects and cancer. Cancer Lett. 356:126–136.
   PubMed Web of Science ®Google Scholar
• Caruso C, Lio D, Cavallone L, Franceschi C. 2004. Aging, longevity, inflammation, and cancer. Ann N Y Acad Sci. 1028:1–13.
   PubMed Web of Science ®Google Scholar
• Collins TS, Lee LF, Ting JP. 2000. Paclitaxel up-regulates interleukin-8 synthesis in human lung carcinoma through an NF-kappaB- and AP-1-dependent mechanism. Cancer Immunol Immunother. 49:78–84.
   PubMed Web of Science ®Google Scholar
• Coppé JP, Desprez PY, Krtolica A, Campisi J. 2010. The senescence-associated secretory phenotype: the dark side of tumor suppression. Annu Rev Pathol. 5:99–118.
   PubMed Web of Science ®Google Scholar
• Desai S, Kumar A, Laskar S, Pandey BN. 2013. Cytokine profile of conditioned medium from human tumor cell lines after acute and fractionated doses of gamma radiation and its effect on survival of bystander tumor cells. Cytokine. 61:54–62.
   PubMed Web of Science ®Google Scholar
• Di Maggio FM, Minafra L, Forte GI, Cammarata FP, Lio D, Messa C, Gilardi MC, Bravatà V. 2015. Portrait of inflammatory response to ionizing radiation treatment. J Inflamm (Lond). 12:14.
   PubMed Web of Science ®Google Scholar
• Formenti SC, Demaria S. 2009. Systemic effects of local radiotherapy. Lancet Oncol. 10:718–726.
   PubMed Web of Science ®Google Scholar
• Franken NAP, Rodermond HM, Stap J, Haveman J, van Bree C. 2006. Clonogenic assay of cells in vitro. Nat Protoc. 1:2315–2319.
   PubMed Web of Science ®Google Scholar
• Frey B, Rubner Y, Kulzer L, Werthmöller N, Weiss EM, Fietkau R, Gaipl US. 2014. Antitumor immune responses induced by ionizing irradiation and further immune stimulation. Cancer Immunol Immunother. 63:29–36.
   PubMed Web of Science ®Google Scholar
• Fujisaki K, Fujimoto H, Sangai T, Nagashima T, Sakakibara M, Shiina N, Kuroda M, Aoyagi Y, Miyazaki M. 2015. Cancer-mediated adipose reversion promotes cancer cell migration via IL-6 and MCP-1. Breast Cancer Res Treat. 150:255–263.
   PubMed Web of Science ®Google Scholar
• Grivennikov SI, Greten FR, Karin M. 2010. Immunity, inflammation, and cancer. Cell. 140:883–899.
   PubMed Web of Science ®Google Scholar
• Hall EJ1, Hei TK. 2003. Genomic instability and bystander effects induced by high-LET radiation. Oncogene. 22:7034–7042.
   PubMed Web of Science ®Google Scholar
• Hong JH, Chiang CS, Campbell IL, Sun JR, Withers HR, McBride WH. 1995. Induction of acute phase gene expression by brain irradiation. Int J Radiat Oncol Biol Phys. 33:619.
   PubMed Web of Science ®Google Scholar
• Kil WJ, Tofilon PJ, Camphausen K. 2012. Post-radiation increase in VEGF enhances glioma cell motility in vitro. Radiat Oncol. 7:25.
   PubMed Web of Science ®Google Scholar
• Kraus-Tiefenbacher U, Bauer L, Scheda A, Schoeber C, Schaefer J, Steil V, Wenz F. 2007. Intraoperative radiotherapy (IOERT) is an option for patients with localized breast recurrences after previous external-beam radiotherapy. BMC Cancer. 7:178.
   PubMed Web of Science ®Google Scholar
• Lacroix M, Leclercq G. 2004. Relevance of breast cancer cell lines as models for breast tumours: an update. Breast Cancer Res Treat. 83:249–289.
   PubMed Web of Science ®Google Scholar
• Lathers DM, Young MR. 2004. Increased aberrance of cytokine expression in plasma of patients with more advanced squamous cell carcinoma of the head and neck. Cytokine. 5:220–228.
   Web of Science ®Google Scholar
• Lau CK, Yang ZF, Ho DW, Ng MN, Yeoh GC, Poon RT, Fan ST. 2009. An Akt/hypoxiainducible factor-1alpha/platelet-derived growth factor-BB autocrine loop mediates hypoxia-induced chemoresistance in liver cancer cells and tumorigenic hepatic progenitor cells. Clin Cancer Res. 15:3462–3471.
   PubMed Web of Science ®Google Scholar
• Lev DC, Onn A, Melinkova VO, Miller C, Stone V, Ruiz M, McGary EC, Ananthaswamy HN, Price JE, Bar-Eli M. 2004. Exposure of melanoma cells to dacarbazine results in enhanced tumor growth and metastasis in vivo. J Clin Oncol. 22:2092–2100.
   PubMed Web of Science ®Google Scholar
• Li XH, Ha CT, Fu D, Xiao M. 2012. REDD1 protects osteoblast cells from gamma radiation-induced premature senescence. PLoS One. 7:e36604.
   PubMed Web of Science ®Google Scholar
• Lumniczky K, Sáfrány G. 2006. Cancer gene therapy: combination with radiation therapy and the role of bystander cell killing in the anti-tumor effect. Pathol Oncol Res. 12:118–124.
   PubMed Web of Science ®Google Scholar
• Minafra L, Bravatà V, Forte GI, Cammarata FP, Gilardi MC, Messa C. 2014. Gene expression profiling of epithelial-mesenchymal transition in primary breast cancer cell culture. Anticancer Res. 34:2173–2183.
   PubMed Web of Science ®Google Scholar
• Minafra L, Bravatà V, Russo G, Forte GI, Cammarata FP, Ripamonti M, Candiano G, Cervello M, Giallongo A, Perconti G, Messa C, Gilardi MC. 2015. Gene expression profiling of MCF10A breast epithelial cells exposed to IOERT. Anticancer Res. 35:6.
   Web of Science ®Google Scholar
• Minafra L, Bravatà V. 2014. Cell and molecular response to IORT treatment. Transl Cancer Res. 3:32–47.
   Web of Science ®Google Scholar
• Minafra L, Norata R, Bravatà V, Viola M, Lupo C, Gelfi C, Messa C. 2012. Unmasking epithelial-mesenchymal transition in a breast cancer primary culture: a study report. BMC Res Notes. 5:343.
   PubMedGoogle Scholar
• Mothersill CE, Moriarty MJ, Seymour CB. 2004. Radiotherapy and the potential exploitation of bystander effects. Int J Radiat Oncol Biol Phys. 2004 58:575–579.
   PubMed Web of Science ®Google Scholar
• Multhoff G, Radons J. 2012. Radiation, inflammation, and immune responses in cancer. Front Oncol. 2:58.
   PubMedGoogle Scholar
• Munro AJ. 2009. Bystander effects and their implications for clinical radiotherapy. J Radiol Prot. 29:A133–A142.
   PubMed Web of Science ®Google Scholar
• Offersen BV, Overgaard M, Kroman N, Overgaard J. 2009. Accelerated partial breast irradiation as part of breast conserving therapy of early breast carcinoma: a systematic review. Radiother Oncol. 90:1–13.
   PubMed Web of Science ®Google Scholar
• Orecchia R, Leonardo MC. 2011. Intraoperative radiation therapy: is it a standard now? Breast. 20:S111–S115.
   PubMed Web of Science ®Google Scholar
• O’Sullivan T, Saddawi-Konefka R, Gross E, Tran M, Mayfield SP, Ikeda H, Bui JD. 2014. Interleukin-17D mediates tumor rejection through recruitment of natural killer cells. Cell Rep. 7:989–998.
   PubMed Web of Science ®Google Scholar
• Prise KM, O’Sullivan JM. 2009. Radiation-induced bystander signalling in cancer therapy. Nat Rev Cancer. 9:351–360.
   PubMed Web of Science ®Google Scholar
• Pucci M, Bravatà V, Forte GI, Cammarata FP, Messa C, Gilardi MC, Minafra L. 2015. Caveolin-1, breast cancer and ionizing radiation. Cancer Genom Proteom. 12:143–152.
   PubMed Web of Science ®Google Scholar
• Raghuram GV, Mishra PK. 2014. Stress induced premature senescence: a new culprit in ovarian tumorigenesis? Indian J Med Res. 140:S120–S129.
   PubMed Web of Science ®Google Scholar
• Rodemann HP, Blaese MA. 2007. Responses of normal cells to ionizing radiation. Semin Radiat Oncol. 17:81–88.
   PubMed Web of Science ®Google Scholar
• Russo G, Casarino C, Arnetta G, Candiano G, Stefano A, Alongi F, Borasi G, Messa C, Gilardi MC. 2012. Dose distribution changes with shielding disc misalignments and wrong orientations in breast IOERT: a Monte Carlo-GEANT4 and experimental study. J Appl Clin Med Phys. 13:3817.
   PubMed Web of Science ®Google Scholar
• Schaue D, Kachikwu EL, McBride WH. 2012. Cytokines in radiobiological responses: a review. Radiat Res. 178:505–523.
   PubMed Web of Science ®Google Scholar
• Scola L, Di Maggio FM, Vaccarino L, Bova M, Forte GI1, Pisano C, Candore G, Colonna-Romano G, Lio D, Ruvolo G, et al. 2014. Role of TGF-β pathway polymorphisms in sporadic thoracic aortic aneurysm: rs900 TGF-β2 is a marker of differential gender susceptibility. Mediators Inflamm. 2014:165758.
   PubMed Web of Science ®Google Scholar
• Scola L, Vaglica M, Crivello A, Palmeri L, Forte GI, Macaluso MC, Giacalone A, Di Noto L, Bongiovanni A, Raimondi C, et al. 2006. Cytokine gene polymorphisms and breast cancer susceptibility. Ann N Y Acad Sci. 1089:104–109.
   PubMed Web of Science ®Google Scholar
• Smith BD, Arthur DW, Buchholz TA, Haffty BG, Hahn CA, Hardenbergh PH, Julian TB, Marks LB, Todor DA, Vicini FA, et al. 2009. Accelerated partial breast irradiation consensus statement from the American Society for Radiation Oncology (ASTRO). Int J Radiat Oncol Biol Phys. 74:987–1001.
   PubMed Web of Science ®Google Scholar
• Sologuren I, Rodríguez-Gallego C, Lara PC. 2014. Immune effects of high dose radiation treatment: implications of ionizing radiation on the development of bystander and abscopal effects. Transl Cancer Res. 3:18–31.
   Web of Science ®Google Scholar
• Veronesi U, Orecchia R, Luini A, Galimberti V, Zurrida S, Intra M, Veronesi P, Arnone P, Leonardi MC, Ciocca M, et al. 2010. Intraoperative radiotherapy during breast conserving surgery: a study on 1,822 cases treated with electrons. Breast Cancer Res Treat. 124:141–151.
   PubMed Web of Science ®Google Scholar
• Wallner P, Arthur D, Bartelink H, Connolly J, Edmundson G, Giuliano A, Goldstein N, Hevezi J, Julian T, Kuske R, et al. 2004. Workshop on partial breast irradiation: state of the art and the science. J Natl Cancer Inst. 96:175–184.
   PubMedGoogle Scholar
• Williams NR, Pigott KH, Brew-Graves C, Keshtgar MR. 2014. Intraoperative radiotherapy for breast cancer. Gland Surg. 3:109–119.
   PubMedGoogle Scholar
• Young AR, Narita M. 2009. SASP reflects senescence. EMBO Rep. 10:228–230.
   PubMed Web of Science ®Google Scholar